PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0600260|obstructive lung disease |
| Sentences | 6 |
| PubMedID- 25006405 | Tada-phild (tadalafil for pulmonary hypertension associated with chronic obstructive lung disease) is the first sufficiently powered randomized clinical trial testing the effect of pde-5i on key clinical and drug safety outcome measures in patients with at least moderate ph due to copd. |
| PubMedID- 26453478 | Purpose: recent imaging studies demonstrated the usefulness of quantitative computed tomographic (ct) analysis assessing pulmonary hypertension (ph) in patients with chronic obstructive lung disease (copd-ph). |
| PubMedID- 25046428 | pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis. |
| PubMedID- 23841910 | Severe obstructive lung disease with pulmonary hypertension may be a contraindication for lung flooding. |
| PubMedID- 21266048 | Background: chronic alveolar hypoxia, due to residence at high altitude or chronic obstructive lung diseases, leads to pulmonary hypertension, which may be further complicated by right heart failure, increasing morbidity and mortality. |
| PubMedID- 23837116 | The evaluation of rv function is important for assessing prognosis in severe pulmonary hypertension associated with chronic obstructive lung disease. |
Page: 1